Coagulation Factors
Coagulation factors are protein components of the blood which serve blood coagulation.
Name
|
Marketing Authorisation Holder
|
License Number
|
License Date
|
Further Information
|
Cluvot 1250 I.E.
|
CSL Behring GmbH
|
PEI.H.11666.02.1 |
07.03.2014 |
PharmNet.Bund
|
Prothromplex NF 600
|
Takeda GmbH
|
PEI.H.11717.01.1 |
13.08.2014 |
PharmNet.Bund
|
Prothromplex NF 500
|
Takeda GmbH
|
PEI.H.11717.02.1 |
21.04.2023 |
PharmNet.Bund
|
FibCLOT
|
Laboratoire Français du Fractionnement et des Biotechnologies, F Les Ulis
|
PEI.H.11771.01.1 |
05.02.2016 |
PharmNet.Bund
|
Fibryga
|
Octapharma GmbH
|
PEI.H.11879.01.1 |
23.06.2017 |
PharmNet.Bund
|
Beriate 2000
|
CC-Pharma GmbH
|
PEI.H.12077.01.1 |
10.03.2021 |
|
Beriate 1000
|
CC-Pharma GmbH
|
PEI.H.12077.02.1 |
06.05.2021 |
|
Haemate P 1000 I.E. FVIII / 2400 I.E. VWF
|
Orifarm GmbH
|
PEI.H.12082.01.1 |
24.03.2021 |
PharmNet.Bund
|
Octanate 1000
|
Orifarm GmbH
|
PEI.H.12088.01.1 |
24.03.2021 |
PharmNet.Bund
|
Beriate 2000
|
Orifarm GmbH
|
PEI.H.12092.02.1 |
19.04.2021 |
|
IMMUNINE 1200 I.E.
|
Orifarm GmbH
|
PEI.H.12094.01.1 |
24.03.2021 |
|
Octanate 1000
|
CC-Pharma GmbH
|
PEI.H.12112.01.1 |
05.07.2021 |
|
Disclaimer
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.
Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.